NPCE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $12.70

Capitalizzazione di Mercato (MRQ) $435M

P/E (TTM) -22.3

EPS (TTM) $-0.57

Ricavi (TTM) $99M

ROE (TTM) -122.1%

D/E Debito/Patrimonio (MRQ) 5.0

Intervallo 52 sett. $9–$20

NPCE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Neuropace, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti220 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$100M

2020-12-31 → 2025-12-31

EPS$-0.66

2020-12-31 → 2025-12-31

Flusso di cassa libero$-11M

2021-12-31 → 2025-12-31

Margine netto-19.3%

2021-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	NPCE	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-22.3media 5 anni ≈-9.8	≈-9.8	·	·
P/S (TTM)	4.4media 5 anni ≈4.0	≈4.0	4.2	Sopravvalutato
P/B (MRQ)	36.6media 5 anni ≈17.5	≈17.5	3.5	Sopravvalutato
EV / EBITDA	-26.2media 5 anni ≈-13.1	≈-13.1	·	·
Prezzo / FCF (TTM)	-37.5media 5 anni ≈-17.9	≈-17.9	·	·
Prezzo / Flusso di cassa (TTM)	-38.7media 5 anni ≈-18.3	≈-18.3	·	·
EV / Ricavi (TTM)	4.5media 5 anni ≈3.6	≈3.6	·	·
EV / FCF (TTM)	-38.1media 5 anni ≈-17.2	≈-17.2	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	22.6media 5 anni ≈17.5	≈17.5	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	NPCE	media 5 anni	Mediana dei peer	Verdetto
Margine lordo (TTM)	79.6%media 5 anni ≈74.0%	≈74.0%	76.2%	Di prim'ordine
Margine Operativo (TTM)	-15.3%media 5 anni ≈-45.4%	≈-45.4%	-14.5%	Debole
EBITDA Margin (Margine EBITDA)	-16.3%media 5 anni ≈-45.4%	≈-45.4%	-14.5%	Debole
Margine di Profitto Netto (TTM)	-19.3%media 5 anni ≈-57.8%	≈-57.8%	-15.2%	Debole
ROA (TTM)	-18.8%media 5 anni ≈-30.8%	≈-30.8%	-17.4%	Sotto la media
ROE (TTM)	-122.1%media 5 anni ≈-152.2%	≈-152.2%	-39.3%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	NPCE	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	5.0media 5 anni ≈3.1	≈3.1	0.7	Debito elevato
Rapporto corrente (MRQ)	4.9media 5 anni ≈7.9	≈7.9	4.8	In linea
Quick Ratio (MRQ)	3.8media 5 anni ≈6.9	≈6.9	3.7	In linea
Debito a lungo termine / Patrimonio netto (MRQ)	5.0media 5 anni ≈3.1	≈3.1	0.6	Debito elevato

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	NPCE	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	25.1%media 5 anni ≈20.3%	≈20.3%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	30.0%media 5 anni ≈22.5%	≈22.5%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	19.4%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	NPCE	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.66media 5 anni ≈$-1.39	≈$-1.39	·	·
Revenue / Share (Ricavi / Azione)	$3.06media 5 anni ≈$2.58	≈$2.58	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.34media 5 anni ≈$-0.94	≈$-0.94	·	·
Cash / Share (Liquidità / Azione)	$0.65media 5 anni ≈$0.56	≈$0.56	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	NPCE	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	1.0media 5 anni ≈0.6	≈0.6	0.7	Di prim'ordine
Inventory Turnover (Rotazione delle scorte)	1.5media 5 anni ≈1.6	≈1.6	2.3	Debole
Receivables Turnover (Rotazione dei crediti)	7.3media 5 anni ≈6.5	≈6.5	7.0	In linea
Revenue / Employee (Ricavi / Dipendente)	≈$454.5K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 20.1%

Prossimo report Nov 02, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 10, 2026	$-0.18	$-0.21	14.6%
31 Marzo 2026	Mag 11, 2026	$-0.20	$-0.23	12.4%
31 Dicembre 2025		$-0.08	$-0.15	48.2%
30 Settembre 2025		$-0.11	$-0.20	45.1%
30 Giugno 2025		$-0.26	$-0.23	-14.5%
31 Marzo 2025		$-0.21	$-0.25	14.7%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 17

Metrica	2025	2024	2023	2022	2021	2020
Revenue	$100M	$80M	$65M	$46M	$45M	$41M
Cost of Revenue	$23M	$21M	$17M	$13M	$12M	$11M
Gross Profit	$77M	$59M	$48M	$32M	$33M	$30M
R&D Expense	$28M	$24M	$21M	$22M	$18M	$16M
SG&A Expense	$19M	$17M	$55M	$51M	$39M	$28M
Operating Expenses	$94M	$81M	$75M	$73M	$57M	$43M
Operating Income	$-16M	$-22M	$-27M	$-41M	$-24M	$-13M
Interest Expense	·	·	$9M	$8M	$7M	$11M
Interest Income	$3M	$3M	$3M	$2M	$448.0K	$41.0K
Other Non-op	$-486.0K	$304.0K	$-315.0K	$-337.0K	$-5M	$218.0K
Income Tax	$0	·	·	·	·	·
Net Income	$-21M	$-27M	$-33M	$-47M	$-36M	$-24M
EPS (Basic)	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17	$-117.85
EPS (Diluted)	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17	$-117.85
Shares (Basic)	32,722,438	29,126,314	25,851,813	24,594,784	16,608,800	204,068
Shares (Diluted)	32,722,438	29,126,314	25,851,813	24,594,784	16,608,800	204,068
EBITDA	$-16M	$-22M	$-27M	$-41M	$-24M	·

Stato Patrimoniale 26

Metrica	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$22M	$13M	$18M	$7M	$19M	$26M
Short-term Investments	$39M	$39M	$48M	$71M	$96M	$12M
Receivables	$13M	$13M	$12M	$7M	$7M	$8M
Inventory	$15M	$13M	$11M	$10M	$8M	$7M
Prepaid Expense	$1M	$2M	$3M	$3M	$2M	$1M
Current Assets	$94M	$81M	$93M	$98M	$133M	$55M
PP&E (Net)	$1M	$1M	$1M	$1M	$603.0K	$515.0K
PP&E (Gross)	$9M	$9M	$9M	$10M	$9M	$9M
Accum. Depreciation	$8M	$8M	$8M	$9M	$8M	$8M
Other Non-current Assets	$113.0K	$15.0K	$15.0K	$21.0K	$21.0K	$23.0K
Total Assets	$106M	$95M	$108M	$114M	$134M	$56M
Accounts Payable	$2M	$3M	$2M	$2M	$1M	$949.0K
Accrued Liabilities	$13M	$10M	$11M	$7M	$8M	$7M
Current Liabilities	$18M	$15M	$16M	$11M	$9M	$10M
Capital Leases	$10M	$12M	$14M	$15M	$0	·
Other Non-current Liabilities	·	·	·	·	$0	$274.0K
Total Liabilities	$87M	$87M	$87M	$79M	$60M	$62M
Long-term Debt	·	·	·	·	$50M	$53M
Total Debt	$59M	$60M	$57M	$53M	$50M	·
Common Stock	$34.0K	$30.0K	$28.0K	$25.0K	$24.0K	$0
Paid-in Capital	$571M	$539M	$524M	$507M	$498M	$240M
Retained Earnings	$-552M	$-531M	$-504M	$-471M	$-424M	$-388M
AOCI	·	·	$0	$-1M	$-272.0K	$33.0K
Stockholders' Equity	$19M	$8M	$21M	$35M	$74M	$-148M
Liabilities + Equity	$106M	$95M	$108M	$114M	$134M	$56M
Shares Outstanding	33,574,759	30,145,039	27,823,465	25,045,751	24,452,999	314,096

Flusso di cassa 9

Metrica	2025	2024	2023	2022	2021	2020
Stock-based Comp	$11M	$10M	$10M	$8M	$4M	$1M
Operating Cash Flow	$-11M	$-18M	$-20M	$-37M	$-25M	$-22M
CapEx	$332.0K	$306.0K	$173.0K	$603.0K	$384.0K	$62.0K
Investing Cash Flow	$-332.0K	$9M	$23M	$24M	$-85M	$-11M
Stock Repurchased	$50M	$0	·	·	·	·
Net Stock Activity	$-50M	·	·	·	·	·
Financing Cash Flow	$20M	$4M	$8M	$490.0K	$103M	$55M
Net Change in Cash	$8M	$-5M	$11M	$-13M	$-7M	$23M
Free Cash Flow	$-11M	$-18M	$-20M	$-37M	$-25M	·

Redditività 6

Metrica	2025	2024	2023	2022	2021	2020
Gross Margin	77.2%	73.9%	73.6%	71.4%	74.0%	·
Operating Margin	-16.3%	-27.1%	-41.5%	-89.6%	-52.5%	·
Net Margin	-21.5%	-34.0%	-50.4%	-103.4%	-79.8%	·
EBITDA Margin	-16.3%	-27.1%	-41.5%	-89.6%	-52.5%	·
ROA	-21.4%	-26.8%	-29.7%	-38.0%	-38.1%	·
ROE	-111.6%	-304.3%	-178.1%	-120.4%	-46.5%	·

Liquidità e Solvibilità 5

Metrica	2025	2024	2023	2022	2021	2020
Current Ratio	5.3	5.4	5.7	8.9	14.3	·
Quick Ratio	4.3	4.3	4.9	7.7	13.2	·
Debt / Equity	3.1	7.4	2.8	1.5	0.7	·
LT Debt / Equity	3.1	7.4	2.8	1.5	0.7	·
Interest Coverage	·	·	-3.2	-5.4	-3.2	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020
Asset Turnover	1.0	0.8	0.6	0.4	0.5	·
Inventory Turnover	1.5	1.7	1.7	1.5	1.6	·
Receivables Turnover	7.3	6.4	6.6	6.2	5.8	·

Per Azione 6

Metrica	2025	2024	2023	2022	2021	2020
Book Value / Share	$0.57	$0.27	$0.74	$1.39	$3.01	·
Revenue / Share	$3.06	$2.74	$2.53	$1.85	$2.72	·
Cash Flow / Share	$-0.34	$-0.62	$-0.76	$-1.50	$-1.48	·
Cash / Share	$0.65	$0.45	$0.65	$0.26	$0.78	·
Dividend / Share	$0.00	$0.00	$0.00	·	·	·
EPS (TTM)	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020
Revenue YoY	25.1%	22.1%	43.7%	0.75%	9.8%	·
Revenue CAGR 3Y	30.0%	20.9%	16.7%	·	·	·
Revenue CAGR 5Y	19.4%	·	·	·	·	·

Valutazione (TTM) 14

Metrica	2025	2024	2023	2022	2021	2020
Revenue TTM	$100M	$80M	$65M	$46M	$45M	·
Net Income TTM	$-21M	$-27M	$-33M	$-47M	$-36M	·
Market Cap	$518M	$337M	$287M	$37M	$246M	·
Enterprise Value	$516M	$344M	$277M	$13M	$181M	·
P/E	-23.4	-12.0	-8.1	-0.8	-4.6	·
P/S	5.2	4.2	4.4	0.8	5.5	·
P/B	27.2	42.1	13.9	1.1	3.4	·
P / Tangible Book	27.2	42.1	13.9	1.1	3.4	·
P / Cash Flow	-47.1	-18.8	-14.6	-1.0	-10.0	·
P / FCF	-45.7	-18.5	-14.4	-1.0	-9.9	·
EV / EBITDA	-31.6	-15.9	-10.2	-0.3	-7.6	·
EV / FCF	-45.5	-18.8	-14.0	-0.3	-7.2	·
EV / Revenue	5.2	4.3	4.2	0.3	4.0	·
Earnings Yield	-4.3%	-8.3%	-12.3%	-128.2%	-21.5%	·

Conto Economico 17

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$23M	$22M	$27M	$27M	$20M	$23M	$21M	$21M	$19M	$18M	$18M	$16M	$17M	$14M	$13M	$11M
Cost of Revenue	$4M	$4M	$6M	$6M	$3M	$5M	$5M	$6M	$5M	$5M	$4M	$4M	$5M	$4M	$4M	$3M
Gross Profit	$19M	$18M	$21M	$21M	$16M	$17M	$16M	$15M	$14M	$13M	$14M	$12M	$12M	$10M	$9M	$8M
R&D Expense	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$6M	$6M	$6M	$5M	$5M	$5M	$5M	$5M	$6M
SG&A Expense	$5M	$5M	$-7M	$5M	$6M	$4M	$-6M	$4M	$5M	$15M	$13M	$13M	$14M	$13M	$14M	$13M
Operating Expenses	$24M	$24M	$22M	$24M	$24M	$22M	$20M	$20M	$20M	$21M	$19M	$18M	$20M	$19M	$19M	$18M
Operating Income	$-5M	$-6M	$-2M	$-3M	$-8M	$-5M	$-4M	$-4M	$-6M	$-8M	$-5M	$-6M	$-8M	$-8M	$-10M	$-10M
Interest Expense	·	·	·	·	·	·	·	·	·	$2M	·	$2M	$2M	$2M	$2M	$2M
Interest Income	$523.0K	$565.0K	$638.0K	$667.0K	$718.0K	$793.0K	$681.0K	$754.0K	$762.0K	$827.0K	$822.0K	$769.0K	$733.0K	$726.0K	$800.0K	$423.0K
Other Non-op	$-41.0K	$-165.0K	$0	$82.0K	$-486.0K	$-82.0K	$-86.0K	$219.0K	$120.0K	$51.0K	$265.0K	$115.0K	$122.0K	$-817.0K	$-146.0K	$-103.0K
Income Tax	·	$0	$0	$0	$0	$0	·	$0	$0	$0	·	$0	$0	$0	·	$0
Net Income	$-6M	$-7M	$-3M	$-3M	$-9M	$-7M	$-5M	$-5M	$-8M	$-9M	$-6M	$-7M	$-9M	$-10M	$-11M	$-12M
EPS (Basic)	$-0.18	$-0.20	$-0.08	$-0.11	$-0.26	$-0.21	$-0.16	$-0.19	$-0.26	$-0.32	$-0.22	$-0.28	$-0.36	$-0.41	$-0.44	$-0.48
EPS (Diluted)	$-0.18	$-0.20	$-0.08	$-0.11	$-0.26	$-0.21	$-0.16	$-0.19	$-0.26	$-0.32	$-0.22	$-0.28	$-0.36	$-0.41	$-0.44	$-0.48
Shares (Basic)	34,104,430	33,716,813	·	33,134,606	32,863,031	31,480,911	·	29,444,625	28,853,216	28,285,176	·	26,017,329	25,472,526	25,097,262	·	24,728,701
Shares (Diluted)	34,104,430	33,716,813	·	33,134,606	32,863,031	31,480,911	·	29,444,625	28,853,216	28,285,176	·	26,017,329	25,472,526	25,097,262	·	24,728,701
EBITDA	$-5M	$-6M	·	$-3M	$-7M	$-5M	·	$-4M	$-6M	$-8M	·	$-6M	$-8M	$-8M	·	$-10M

Stato Patrimoniale 24

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$13M	$15M	$22M	$21M	$23M	$27M	$13M	$15M	$13M	$13M	$18M	$10M	$8M	$7M	$7M	$6M
Short-term Investments	$39M	$39M	$39M	$39M	$39M	$39M	$39M	$41M	$43M	$46M	$48M	$52M	$56M	$61M	$71M	·
Receivables	$15M	$15M	$15M	$15M	$14M	$15M	$13M	$12M	$11M	$12M	$12M	$11M	$11M	$9M	$7M	$8M
Inventory	$18M	$17M	$17M	$18M	$16M	$14M	$13M	$12M	$11M	$11M	$11M	$10M	$10M	$11M	$10M	$9M
Prepaid Expense	$1M	$2M	$1M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$3M	$3M	$3M
Current Assets	$86M	$87M	$94M	$95M	$94M	$97M	$81M	$83M	$80M	$84M	$93M	$84M	$87M	$90M	$98M	$104M
PP&E (Net)	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$998.0K	$1M	$1M	$949.0K	$976.0K	$1M	$1M	$894.0K
PP&E (Gross)	$10M	$10M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$10M	$10M	$10M	$10M	$10M
Accum. Depreciation	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$9M	$9M	$9M	$9M	$9M
Other Non-current Assets	$98.0K	$106.0K	$113.0K	$120.0K	$87.0K	$15.0K	$15.0K	$15.0K	$15.0K	$15.0K	$15.0K	$15.0K	$21.0K	$21.0K	$21.0K	$21.0K
Total Assets	$97M	$99M	$106M	$107M	$106M	$110M	$95M	$96M	$94M	$99M	$108M	$99M	$102M	$106M	$114M	$120M
Accounts Payable	$4M	$5M	$2M	$5M	$5M	$4M	$3M	$2M	$2M	$3M	$2M	$1M	$2M	$2M	$2M	$1M
Accrued Liabilities	$11M	$9M	$13M	$12M	$10M	$8M	$10M	$10M	$8M	$7M	$11M	$10M	$8M	$7M	$7M	$8M
Current Liabilities	$17M	$16M	$18M	$20M	$17M	$15M	$15M	$15M	$13M	$13M	$16M	$13M	$12M	$10M	$11M	$9M
Capital Leases	$9M	$9M	$10M	$10M	$11M	$11M	$12M	$12M	$13M	$13M	$14M	$14M	$15M	$15M	$15M	$16M
Total Liabilities	$85M	$84M	$87M	$89M	$87M	$86M	$87M	$86M	$85M	$85M	$87M	$83M	$81M	$79M	$79M	$77M
Total Debt	$59M	$59M	·	$59M	$59M	$60M	·	$59M	$59M	$58M	·	$56M	$55M	$54M	·	$52M
Common Stock	$34.0K	$34.0K	$34.0K	$33.0K	$33.0K	$33.0K	$30.0K	$30.0K	$29.0K	$29.0K	$28.0K	$26.0K	$26.0K	$25.0K	$25.0K	$25.0K
Paid-in Capital	$577M	$574M	$571M	$568M	$566M	$562M	$539M	$535M	$530M	$527M	$524M	$514M	$512M	$509M	$507M	$504M
Retained Earnings	$-565M	$-559M	$-552M	$-550M	$-546M	$-538M	$-531M	$-526M	$-520M	$-513M	$-504M	$-498M	$-490M	$-481M	$-471M	$-460M
AOCI	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$-1M	$-1M
Stockholders' Equity	$12M	$14M	$19M	$19M	$19M	$24M	$8M	$10M	$10M	$14M	$21M	$16M	$21M	$27M	$35M	$43M
Liabilities + Equity	$97M	$99M	$106M	$107M	$106M	$110M	$95M	$96M	$94M	$99M	$108M	$99M	$102M	$106M	$114M	$120M
Shares Outstanding	34,282,567	33,909,408	33,574,759	33,280,887	33,044,371	32,751,240	30,145,039	29,777,966	29,139,206	28,717,452	27,823,465	26,244,935	25,816,929	25,352,204	25,045,751	24,864,119

Flusso di cassa 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$2M	$2M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$3M	$2M	$2M	$2M
Operating Cash Flow	$-4M	$-6M	$506.0K	$-2M	$-2M	$-7M	$-5M	$-2M	$-4M	$-8M	$-3M	$-2M	$-4M	$-10M	$-8M	$-7M
CapEx	$125.0K	$117.0K	$97.0K	$30.0K	$168.0K	$37.0K	$39.0K	$100.0K	$63.0K	$104.0K	$32.0K	$9.0K	$0	$132.0K	$102.0K	$31.0K
Investing Cash Flow	$-125.0K	$-117.0K	$-97.0K	$-30.0K	$-168.0K	$-37.0K	$2M	$1M	$3M	$2M	$3M	$4M	$5M	$10M	$9M	$7M
Stock Repurchased	$0	$0	$0	$0	$0	$50M	$0	$0	$0	$0	·	·	·	·	·	·
Net Stock Activity	·	$0	·	·	·	$-50M	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$1M	$-166.0K	$635.0K	$-235.0K	$-2M	$21M	$848.0K	$3M	$509.0K	$72.0K	$8M	$-27.0K	$195.0K	$-255.0K	$-138.0K	$-8.0K
Net Change in Cash	$-3M	$-6M	$1M	$-2M	$-4M	$14M	$-2M	$3M	$-154.0K	$-5M	$8M	$2M	$1M	$115.0K	$917.0K	$-14.0K
Free Cash Flow	·	$-6M	·	·	·	$-8M	·	·	·	$-8M	·	·	·	$-10M	·	·

Redditività 6

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	82.8%	81.8%	·	77.4%	77.1%	77.0%	·	73.2%	73.4%	73.6%	·	74.5%	72.5%	71.7%	·	71.4%
Operating Margin	-22.5%	-25.2%	·	-9.5%	-29.0%	-22.9%	·	-20.2%	-32.4%	-41.6%	·	-36.2%	-47.6%	-57.5%	·	-91.4%
Net Margin	-27.2%	-30.3%	·	-12.8%	-36.8%	-29.2%	·	-25.9%	-39.0%	-49.2%	·	-44.2%	-55.3%	-71.7%	·	-105.6%
EBITDA Margin	-22.5%	-25.2%	·	-9.5%	-29.0%	-22.9%	·	-20.2%	-32.4%	-41.6%	·	-36.2%	-47.6%	-57.5%	·	-91.4%
ROA	-6.1%	-6.4%	·	-3.4%	-8.6%	-6.3%	·	-5.6%	-7.6%	-8.7%	·	-6.6%	-8.3%	-8.8%	·	-9.0%
ROE	-39.6%	-34.5%	·	-24.7%	-59.0%	-34.1%	·	-41.6%	-48.3%	-42.7%	·	-24.3%	-24.6%	-23.0%	·	-18.8%

Liquidità e Solvibilità 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.9	5.4	·	4.9	5.5	6.6	·	5.6	6.4	6.4	·	6.6	7.5	9.1	·	11.1
Quick Ratio	3.8	4.3	·	3.8	4.4	5.6	·	4.6	5.3	5.4	·	5.7	6.5	7.8	·	1.4
Debt / Equity	5.0	4.1	·	3.2	3.0	2.5	·	6.0	6.0	4.0	·	3.4	2.6	2.0	·	1.2
LT Debt / Equity	5.0	4.1	·	3.2	3.0	2.5	·	6.0	6.0	4.0	·	3.4	2.6	2.0	·	1.2
Interest Coverage	·	·	·	·	·	·	·	·	·	-3.3	·	-2.7	-3.7	-4.2	·	-5.4

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.2	0.2	·	0.3	0.2	0.2	·	0.2	0.2	0.2	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.2	0.3	·	0.4	0.4	0.4	·	0.5	0.5	0.4	·	0.5	0.5	0.4	·	0.4
Receivables Turnover	1.6	1.5	·	2.1	1.9	1.7	·	1.8	1.7	1.7	·	1.7	1.7	1.6	·	1.5

Per Azione 6

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.35	$0.43	·	$0.56	$0.59	$0.74	·	$0.33	$0.34	$0.50	·	$0.62	$0.82	$1.08	·	$1.75
Revenue / Share	$0.67	$0.65	·	$0.83	$0.72	$0.72	·	$0.72	$0.67	$0.64	·	$0.63	$0.65	$0.58	·	$0.45
Cash Flow / Share	·	$-0.17	·	·	·	$-0.24	·	·	·	$-0.27	·	·	·	$-0.39	·	·
Cash / Share	$0.37	$0.44	·	$0.62	$0.69	$0.82	·	$0.52	$0.44	$0.45	·	$0.37	$0.30	$0.27	·	$0.23
Dividend / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	·	·	·	·	·	·	·	·	·	·
EPS (TTM)	$-0.57	$-0.65	·	$-0.74	$-0.82	$-0.82	·	$-0.99	$-1.08	$-1.18	·	$-1.49	$-1.69	$-1.85	·	$29.91

Valutazione (TTM) 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$99M	$96M	·	$91M	$85M	$84M	·	$76M	$72M	$69M	·	$60M	$55M	$49M	·	$44M
Net Income TTM	$-19M	$-22M	·	$-24M	$-26M	$-25M	·	$-28M	$-30M	$-32M	·	$-38M	$-42M	$-46M	·	$-47M
Market Cap	$545M	$446M	·	$343M	$368M	$403M	·	$208M	$220M	$379M	·	$255M	$116M	$118M	·	$93M
Enterprise Value	$552M	$451M	·	$342M	$365M	$396M	·	$210M	$224M	$378M	·	$250M	$107M	$104M	·	$140M
P/E	-27.9	-20.2	·	-13.9	-13.6	-15.0	·	-7.0	-7.0	-11.2	·	-6.5	-2.7	-2.5	·	0.1
P/S	5.5	4.7	·	3.8	4.4	4.8	·	2.7	3.1	5.5	·	4.2	2.1	2.4	·	2.1
P/B	45.8	30.9	·	18.5	18.9	16.6	·	21.1	22.3	26.4	·	15.6	5.5	4.3	·	2.1
P / Tangible Book	45.8	30.9	·	18.5	18.9	16.6	·	21.1	22.3	26.4	·	15.6	5.5	4.3	·	2.1
P / Cash Flow	·	-75.6	·	·	·	-53.8	·	·	·	-50.4	·	·	·	-12.1	·	·
EV / Revenue	5.6	4.7	·	3.8	4.3	4.7	·	2.7	3.1	5.5	·	4.2	2.0	2.1	·	3.2
Earnings Yield	-3.6%	-4.9%	·	-7.2%	-7.4%	-6.7%	·	-14.2%	-14.3%	-8.9%	·	-15.3%	-37.6%	-39.9%	·	797.6%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$100M	$80M	$65M	$46M	$45M
Margine Lordo %	77.2%	73.9%	73.6%	71.4%	74.0%
Margine Operativo %	-16.3%	-27.1%	-41.5%	-89.6%	-52.5%
Utile netto	$-21M	$-27M	$-33M	$-47M	$-36M
EPS Diluito	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	3.1	7.4	2.8	1.5	0.7
Rapporto corrente	5.3	5.4	5.7	8.9	14.3
Quick Ratio	4.3	4.3	4.9	7.7	13.2

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-11M	$-18M	$-20M	$-37M	$-25M

Proprietari istituzionali (13F) 118 filer · $464.2M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 118

Valore detenuto $464.2M

Nuove posizioni 19

Posizioni chiuse 18

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
19 (-10 vs trimestre precedente)	18 (+8 vs trimestre precedente)	47 (+9 vs trimestre precedente)	35 (0 vs trimestre precedente)	+120K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
Polar Capital Holdings Plc	$52.406.873	3.298.104	11,29%	Azioni
Soleus Capital Management, L.P.	$46.257.729	2.911.122	9,96%	Azioni
First Light Asset Management, LLC	$45.463.944	2.861.167	9,79%	Azioni
MORGAN STANLEY	$42.178.273	2.654.391	9,09%	Azioni
BlackRock, Inc.	$39.369.112	2.477.603	8,48%	Azioni
ORBIMED ADVISORS LLC	$23.916.436	1.505.125	5,15%	Azioni
Driehaus Capital Management LLC	$22.999.043	1.447.391	4,95%	Azioni
VANGUARD GROUP INC	$22.885.600	1.482.228	4,93%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$19.498.174	1.227.072	4,20%	Azioni
DEUTSCHE BANK AG\	$14.919.423	938.919	3,21%	Azioni
ARMISTICE CAPITAL, LLC	$10.995.880	692.000	2,37%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$10.589.998	666.300	2,28%	Azioni
Kent Lake PR LLC	$10.310.000	1.000.000	2,22%	Azioni
KOTLER KEVIN	$9.749.866	631.468	2,10%	Azioni
FMR LLC	$8.815.311	554.771	1,90%	Azioni
STATE STREET CORP	$8.741.597	550.132	1,88%	Azioni
SILVERCREST ASSET MANAGEMENT GROUP LLC	$5.468.130	344.124	1,18%	Azioni
NORTHERN TRUST CORP	$4.131.798	260.025	0,89%	Azioni
Qube Research & Technologies Ltd	$3.515.456	221.237	0,76%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.501.695	220.371	0,75%	Azioni
Palumbo Wealth Management LLC	$3.324.173	209.199	0,72%	Azioni
ESSEX INVESTMENT MANAGEMENT CO LLC	$3.316.291	208.703	0,71%	Azioni
ALGERT GLOBAL LLC	$2.936.059	184.774	0,63%	Azioni
VANGUARD FIDUCIARY TRUST CO	$2.900.465	182.534	0,62%	Azioni
JPMORGAN CHASE & CO	$2.864.831	173.311	0,62%	Azioni
HighMark Wealth Management LLC	$2.590.070	163.000	0,56%	Azioni
Russell Investments Group, Ltd.	$2.576.783	162.164	0,56%	Azioni
D. E. Shaw & Co., Inc.	$2.559.577	161.081	0,55%	Azioni
GOLDMAN SACHS GROUP INC	$2.376.604	149.566	0,51%	Azioni
CITADEL ADVISORS LLC	$2.046.632	128.800	0,44%	Azioni
LAZARD ASSET MANAGEMENT LLC	$2.029.598	127.728	0,44%	Azioni
PANAGORA ASSET MANAGEMENT INC	$1.812.398	114.059	0,39%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.774.897	111.699	0,38%	Azioni
TUDOR INVESTMENT CORP ET AL	$1.745.898	109.874	0,38%	Azioni
Nuveen, LLC	$1.581.023	99.498	0,34%	Azioni
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	$1.506.372	94.800	0,32%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$1.393.188	87.677	0,30%	Azioni
Man Group plc	$1.335.920	84.073	0,29%	Azioni
NORGES BANK	$1.269.611	79.900	0,27%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.236.735	77.831	0,27%	Azioni
Legato Capital Management LLC	$1.117.607	70.334	0,24%	Azioni
SEI INVESTMENTS CO	$987.993	62.177	0,21%	Azioni
Bank of New York Mellon Corp	$921.255	57.977	0,20%	Azioni
TWO SIGMA ADVISERS, LP	$788.984	51.100	0,17%	Azioni
Informed Momentum Co LLC	$630.134	39.656	0,14%	Azioni
AQR CAPITAL MANAGEMENT LLC	$570.769	35.920	0,12%	Azioni
JANE STREET GROUP, LLC	$547.220	34.438	0,12%	Azioni
RHUMBLINE ADVISERS	$503.131	31.664	0,11%	Azioni
BARCLAYS PLC	$492.765	31.011	0,11%	Azioni
MILLENNIUM MANAGEMENT LLC	$486.536	30.619	0,10%	Azioni

Mostra tutti i 118 proprietari istituzionali →

Attivisti e proprietari del 5%+ 1 partecipazione

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Accelmed Partners II LP, Accelmed Partners II GP, L.P., Accelmed Partners II, LLC, Uri Geiger ×2 depositi	23 Novembre 2022	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 17 insider · 6 dirigenti · 11 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Joel Becker	CHIEF EXECUTIVE OFFICER	03 Settembre 2026 F	138.000	0	$0
Michael Favet	Chief Executive Officer	21 Febbraio 2023 A	407.080	0	$0
Patrick F. Williams	Chief Financial Officer	20 Settembre 2026 F	67.508	0	$0
Rebecca Kuhn	CHIEF FINANCIAL OFFICER	03 Giugno 2025 F	131.613	0	$0
Martha Morrell	CHIEF MEDICAL OFFICER	24 Settembre 2026 F	51.357	1	$-399.250
Irina Ridley	Chief Legal Officer/Secretary	20 Febbraio 2023 A	141.139	0	$0
Rakhi Kumar	Direttore	19 Giugno 2026 A	23.039	0	$0
Uri Geiger	Direttore	19 Giugno 2026 A	18.537	0	$0
Frank M Fischer	Direttore	19 Giugno 2026 A	599.534	0	$0
Renee Ryan	Direttore	05 Giugno 2026 A	2.890	0	$0
Lisa Andrade	Direttore	05 Giugno 2026 A	2.890	0	$0
Scott R Huennekens	Direttore	05 Giugno 2026 A	2.890	0	$0
Joseph Lacob	Direttore	20 Marzo 2026 A	14.754	0	$0
Greg Shaw Garfield	Direttore	13 Giugno 2022 A	5.614.384	0	$0
Evan Norton	Direttore	21 Aprile 2021 A	4.042.657	0	$0
KCK LTD.	Proprietario del 10%	20 Febbraio 2025 S	0	0	$0
Accelmed Partners II L.P.	Proprietario del 10%	22 Novembre 2022 P	4.432.948	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 11 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IBRN · iShares Trust	0,38%	2.057 SH	11 Settembre 2026	Giornaliero
IWC · iShares Trust	0,09%	89.476 SH	11 Settembre 2026	Giornaliero
IWO · iShares Trust	0,02%	248.901 SH	11 Settembre 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,02%	28.462 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,01%	676.027 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,01%	12.674 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	152.437 SH	19 Agosto 2026	Giornaliero
IWV · iShares Trust	0,00%	11.385 SH	03 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,00%	290.278 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	908.479 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	1.828 SH	19 Agosto 2026	Giornaliero

NPCE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 15 analisti COMPRA

Target mediano $20.00 +57,5%

4 26,7% Acquisto forte

10 66,7% Compra

1 6,7% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

10 analisti · 2026-09-27

Target medio $20.00 +57,5%

← Sotto tutti i target Prezzo attuale $12.70

Basso$18.00 Media$20.00 Alto$22.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
NPCE	$518M	-23.4	25.1%	-21.5%	-111.6%	77.2%
DCTH	$350M	144.3	129.1%	3.2%	2.5%	86.2%
SENS	$228M	-3.3	56.9%	-196.0%	-88.7%	44.7%
TCMD	$651M	35.4	12.5%	5.8%	9.2%	75.9%
SGHT	$424M	-10.7	-3.1%	-49.7%	-57.4%	86.2%
SI	$295M	-3.1	49.6%	-85.3%	-129.1%	76.5%
CARL	$329M	-5.8	85.9%	-58.7%	-375.2%	75.3%
OFIX	$604M	-6.5	2.9%	-11.2%	-20.3%	68.8%
OBIO	$237M	-3.7	1169.2%	-157.4%	-195.7%	·
CLPT	$402M	-15.2	17.8%	-69.1%	-106.9%	61.4%
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

NPCE Neuropace, Inc. - Common Stock